Cargando…

Opportunity Cost for Early Treatment of Chagas Disease in Mexico

BACKGROUND: Given current neglect for Chagas disease in public health programs in Mexico, future healthcare and economic development policies will need a more robust model to analyze costs and impacts of timely clinical attention of infected populations. METHODOLOGY/PRINCIPAL FINDINGS: A Markov deci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramsey, Janine M., Elizondo-Cano, Miguel, Sanchez-González, Gilberto, Peña-Nieves, Adriana, Figueroa-Lara, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990484/ https://www.ncbi.nlm.nih.gov/pubmed/24743112 http://dx.doi.org/10.1371/journal.pntd.0002776

Ejemplares similares

Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico
por: Sánchez-González, Gilberto, et al.
Publicado: (2016)

Barriers to Treatment Access for Chagas Disease in Mexico
por: Manne, Jennifer M., et al.
Publicado: (2013)

Ecologic Niche Modeling and Potential Reservoirs for Chagas Disease, Mexico.
por: Peterson, A. Townsend, et al.
Publicado: (2002)

Community resilience and Chagas disease in a rural region of Mexico
por: Rangel, José Antonio Santana, et al.
Publicado: (2016)

Social Representations and Practices Towards Triatomines and Chagas Disease in Calakmul, México
por: Valdez-Tah, Alba, et al.
Publicado: (2015)

Chagas Disease in Pregnant Women from Endemic Regions Attending the Hospital General de Mexico, Mexico City
por: Chakravarti, Indira, et al.
Publicado: (2022)

Automated identification of insect vectors of Chagas disease in Brazil and Mexico: the Virtual Vector Lab
por: Gurgel-Gonçalves, Rodrigo, et al.
Publicado: (2017)

Phylogeny and Niche Conservatism in North and Central American Triatomine Bugs (Hemiptera: Reduviidae: Triatominae), Vectors of Chagas' Disease
por: Ibarra-Cerdeña, Carlos N., et al.
Publicado: (2014)

Chagas Disease and the London Declaration on Neglected Tropical Diseases
por: Tarleton, Rick L., et al.
Publicado: (2014)

Opportunities for Improved Chagas Disease Vector Control Based on Knowledge, Attitudes and Practices of Communities in the Yucatan Peninsula, Mexico
por: Rosecrans, Kathryn, et al.
Publicado: (2014)

Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers
por: Figueroa-Lara, Alejandro, et al.
Publicado: (2016)

Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus
por: Alonso-Padilla, Julio, et al.
Publicado: (2020)

Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts
por: Olivera, Mario J., et al.
Publicado: (2022)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

Ecological Connectivity of Trypanosoma cruzi Reservoirs and Triatoma pallidipennis Hosts in an Anthropogenic Landscape with Endemic Chagas Disease
por: Ramsey, Janine M., et al.
Publicado: (2012)

An innovative ecohealth intervention for Chagas disease vector control in Yucatan, Mexico
por: Waleckx, Etienne, et al.
Publicado: (2015)

Including unpublished surveys in reviews on Chagas disease in Mexico
por: Buekens, Pierre, et al.
Publicado: (2020)

The Costs of Preventing and Treating Chagas Disease in Colombia
por: Castillo-Riquelme, Marianela, et al.
Publicado: (2008)

Visión de México y sus artistas : siglo XX /
por: Lara Elizondo, Lupina
Publicado: (2000)

Chagas Disease in a Domestic Transmission Cycle in Southern Texas, USA
por: Beard, Charles B., et al.
Publicado: (2003)

The Low Variability of Tc24 in Trypanosoma cruzi TcI as an Advantage for Chagas Disease Prophylaxis and Diagnosis in Mexico
por: Becker, Ingeborg, et al.
Publicado: (2023)

Using the health belief model to identify communication opportunities to prevent Chagas disease in Southern Ecuador
por: Patterson, Nelson M., et al.
Publicado: (2018)

Continuing evidence of Chagas disease along the Texas-Mexico border
por: Nolan, Melissa S., et al.
Publicado: (2018)

Modeling Chagas Disease at Population Level to Explain Venezuela's Real Data
por: González-Parra, Gilberto, et al.
Publicado: (2015)

Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease
por: Aguilera, Elena, et al.
Publicado: (2022)

Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study
por: González, Nicolás Leonel, et al.
Publicado: (2022)

Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease
por: Ramsey, Janine M, et al.
Publicado: (2015)

Early detection of left ventricular diastolic dysfunction in Chagas' disease
por: Cianciulli, Tomás F, et al.
Publicado: (2006)

The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
por: Ricci, Alejandro D., et al.
Publicado: (2023)

Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care
por: Saraiva, Roberto M, et al.
Publicado: (2021)

Treatment of Chagas Disease in the United States
por: Meymandi, Sheba, et al.
Publicado: (2018)

Lexicón del noreste de México
por: Elizondo Elizondo, Ricardo
Publicado: (1996)

Intermediate Monocytes and Cytokine Production Associated With Severe Forms of Chagas Disease
por: Gómez-Olarte, Sergio, et al.
Publicado: (2019)

Early Detection of Chronic Asymptomatic Chagas Infection
por: de la Rosa, Ezequiel, et al.
Publicado: (2018)

Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease
por: Saraiva, Roberto M., et al.
Publicado: (2022)

Industrial opportunities in Mexico.
Publicado: (1971)

Congenital Chagas disease: an update
por: Carlier, Yves, et al.
Publicado: (2015)

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
por: Martínez-Peinado, Nieves, et al.
Publicado: (2021)

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics
por: Nenadić, Ilija, et al.
Publicado: (2017)

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy
por: González-Alcaide, Gregorio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oihf8mlvbuljd5s56snq10rodr